198969-19-6 Usage
Uses
Used in Pharmaceutical Industry:
Ramipril is used as an antihypertensive and heart failure treatment for managing high blood pressure and improving the heart's ability to pump blood effectively. It functions by inhibiting the ACE enzyme, leading to relaxation of blood vessels and reduced fluid retention in the body.
Common side effects of Ramipril include dizziness, cough, and increased blood potassium levels. It is important to consult a healthcare professional before using this medication, as it may interact with other drugs or medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 198969-19-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,8,9,6 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 198969-19:
(8*1)+(7*9)+(6*8)+(5*9)+(4*6)+(3*9)+(2*1)+(1*9)=226
226 % 10 = 6
So 198969-19-6 is a valid CAS Registry Number.
InChI:InChI=1/C17H23NO5/c1-17(2,3)23-16(20)18-11-13(10-14(18)15(19)21-4)22-12-8-6-5-7-9-12/h5-9,13-14H,10-11H2,1-4H3/t13-,14-/m1/s1
198969-19-6Relevant articles and documents
PYRROLIDINE GPR40 MODULATORS
-
Paragraph 00204, (2014/06/11)
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.
Synthesis and biological properties of new constrained CCK-B antagonists: Discrimination of two affinity states of the CCK-B receptor on transfected CHO cells
Bellier, Bruno,McCort-Tranchepain, Isabelle,Ducos, Bertrand,Danascimento, Sophie,Meudal, Hervé,Noble, Florence,Garbay, Christiane,Roques, Bernard P.
, p. 3947 - 3956 (2007/10/03)
To improve our knowledge of the bioactive conformation of CCK-B antagonists, we have developed a new series of constrained dipeptoids whose synthesis and biochemical properties are reported here. These compounds, of general structure N(α)-[(2-adamantyloxy